India to United States: Fulvestrant Export Trade Route
India has recorded 31 verified shipments of Fulvestrant exported to United States, representing a combined trade value of $4.0M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $128.9K USD. The leading Indian exporter is ALEMBIC PHARMACEUTICALS LIMITED, which accounts for 36% of total export value with 7 shipments worth $1.5M USD. On the buying side, J KNIPPER COMPANY is the largest importer in United States with $1.1M USD in purchases. The top 3 suppliers — ALEMBIC PHARMACEUTICALS LIMITED, DR REDDYS LABORATORIES LIMITED, AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Fulvestrant corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $4.0M USD. The route is dominated by ALEMBIC PHARMACEUTICALS LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's fulvestrant manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $128.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with fulvestrant's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 28.8%, placing it at rank #2 among India's top fulvestrant export destinations globally.
On the import side, key buyers of Indian fulvestrant in United States include J KNIPPER COMPANY, XXNEAXXEU XXMITXX, DR REDDYS LABORATORIES INC and 14 others. J KNIPPER COMPANY is the single largest importer with 5 shipments valued at $1.1M USD.
